Healthtech Collaboration FB Rice's January 2026 partnership with ANDHealth to deliver IP and R&D tax expertise to digital and connected health companies highlights a clear growth vector in healthtech. This aligns IP strategy with commercialization support, enabling faster paths to market for startups and scale-ups. Target BD outreach to digital health accelerators, CROs, universities with healthtech programs, and medtech corporates needing end-to-end IP, licensing, and tax advisory across Australia and SE Asia.

APAC IP Leadership With established offices across Australia, New Zealand, and Southeast Asia, FB Rice is well positioned to manage regional patent portfolios and enforcement programs for multinational tech and life sciences clients. Opportunities include integrated APAC IP programs, regional filing across key markets, freedom-to-operate analyses, and cross-border licensing, particularly for biotech, medical devices, and software-enabled devices. Leverage track record and client wins to win mid-market to enterprise engagements seeking global IP management.

Academic Partnering FB Rice's deep relationships with CSIRO, universities, and innovation hubs position them as a preferred partner for university tech transfer offices and spin-outs. Propose bundled offerings for patent drafting and prosecution, technology licensing counsel, and R&D tax advisory to accelerate commercialization and attract industry collaborations and investment.

Awarded Service Edge Winning nine Australian Client Choice Awards and achieving a Gold Tier ranking for Patent Prosecution signals strong client outcomes and service quality in regulated sectors. Use these credentials to engage enterprise clients seeking risk-managed IP programs, value-based pricing, and long-term partnerships across biotech, engineering, and digital health.

Culture Driven Service Strategic investment in people leadership and a multilingual, multidisciplinary team underpins consistent, high-touch client service. This capability is attractive to global firms and large corporates needing complex IP work across borders, complex prosecution strategies, and seamless project management.